Creative Diagnostics Supports COVID-19 Testing with Antigen Lateral Flow Assay Development
Nov.06, 2020 in
News
As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now introduces COVID-19 Antigen Lateral Flow Assay Development, including the SARS-CoV-2 nucleoprotein antibody pair for rapid COVID-19 antigen assays to equip healthcare workers for rapid COVID-19 antigen detection.
Comments Off on Creative Diagnostics Supports COVID-19 Testing with Antigen Lateral Flow Assay Development